Table 1 Clinical information of included PDAC patients in TCGA
From: Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
Characteristics | Level | Samples (percentage) |
|---|---|---|
Total | Â | 141 |
Status (%) | Alive | 60 (42.6) |
Dead | 81 (57.4) | |
Age (%) | Old | 70 (49.6) |
Young | 71 (50.4) | |
Gender (%) | Female | 67 (47.5) |
Male | 74 (52.5) | |
Tumor_stage (%) | I | 13 (9.2) |
II | 121 (85.8) | |
III/IV | 6 (4.3) | |
NA | 1 (0.7) | |
N.stage (%) | N0 | 37 (26.2) |
N1 | 103 (73.0) | |
NA | 1 (0.7) | |
T.stage (%) | T1/T2 | 21 (14.9) |
T3/T4 | 119 (84.4) | |
NA | 1 (0.7) | |
M.stage (%) | M0 | 65 (46.1) |
M1 | 3 (2.1) | |
MX | 73 (51.8) | |
Tumor site (%) | Head | 107 (75.9) |
Other | 34 (24.1) | |
Malignancy (%) | Malignancy | 9 (6.4) |
Not | 132 (93.6) | |
Grade (%) | G1/G2 | 100 (70.9) |
G3/G4 | 40 (28.4) | |
NA | 1 (0.7) |